Ignite Creation Date:
2024-05-06 @ 12:28 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03767478
Status:
RECRUITING
Last Update Posted:
2023-07-17
First Post:
2018-11-27
Brief Title:
Neuromuscular Electrical Stimulation For The Treatment of Diabetic Neuropathy
Sponsor:
Imperial College London
Organization:
Imperial College London
Study Overview
Official Title:
Neuromuscular Electrical Stimulation For The Treatment Of Diabetic Neuropathy A Multicentre Double-blind Pilot Randomised Sham-controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NMES-DN
Brief Summary:
Diabetic neuropathy DN is the most common complication of diabetes affecting almost 50 of people with diabetes over the course of their lives Symptoms vary from numbness to burning aching and hypersensitivity in the lower limbs indicative of sensory nerve loss Motor neurons can also be affected leading to muscle weakness and mobility issues thus preventing patients from engaging in daily routines Further sequelae include foot ulceration and Charcot neuroarthropathy which are risk factors for lower limb amputation and mortality In the United Kingdom the annual costs of DN alone exceed 300 million with further complications expected to cost an additional 1 billion Currently management strategies for DN focus on prevention and pain management Neuromuscular electrical stimulation NMES is a novel nonpharmacological intervention for people with DN NMES is the application of electrical impulses which are of sufficiency intensity to improve artificial contraction of the muscle tissue and may help with DN by improving nerve conductivity through direct stimulation of the nerves
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NRES REC ID | OTHER | 18NE0281 | None |
| IRAS ID | OTHER | None | None |